Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial
Martín, Miguel, Prof, Ruiz, Amparo, MD, Muñoz, Monserrat, MD, Balil, Ana, MD, García-Mata, Jesús, MD, Calvo, Lourdes, MD, Carrasco, Eva, MD, Mahillo, Esther, PhD, Casado, Antonio, MD, García-Saenz, José Ángel, MD, Escudero, M José, BSc, Guillem, Vicente, MD, Jara, Carlos, MD, Ribelles, Nuria, MD, Salas, Fernando, MD, Soto, Celia, MD, Morales-Vasquez, Flavia, MD, Rodríguez, César A, MD, Adrover, Encarna, MD, Mel, José Ramón, MD
Published in The lancet oncology (01.03.2007)
Published in The lancet oncology (01.03.2007)
Get full text
Journal Article
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer : a lung cancer Galician group phase II study
CASAL, Joaquin, AMENEDO, Margarita, RAMON MEL, Jose, MIGUEL ANTON, Luis, RODRIGUEZ-LOPEZ, Rubén, LOPEZ-LOPEZ, Rafael, GONZALEZ-AGEITOS, Ana, CASTELLANOS, Javier, CONSTENLA, Manuel, TISAIRE, José L
Published in Cancer chemotherapy and pharmacology (01.10.2007)
Published in Cancer chemotherapy and pharmacology (01.10.2007)
Get full text
Journal Article
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer
Grande, Carlos, Quintero, Guillermo, Candamio, Sonia, París Bouzas, Lorena, Villanueva, María José, Campos, Begoña, Gallardo, Elena, Alvarez, Elena, Casal, Joaquín, Mel, José Ramón
Published in Journal of geriatric oncology (01.04.2013)
Published in Journal of geriatric oncology (01.04.2013)
Get full text
Journal Article
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment
Vazquez-Estevez, Sergio, Varela, Silvia, Campos, Begoña, Álvarez, Elena, Quintero, Guillermo, Mel, Jose Ramón
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study
Alba, Emilio, Ruiz-Borrego, Manuel, Margelí, Mireia, Rodríguez-Lescure, Álvaro, Sánchez-Rovira, Pedro, Ruiz, Amparo, Mel-Lorenzo, Jose Ramón, Ramos-Vázquez, Manuel, Ribelles, Nuria, Calvo, Elisa, Casado, Antonio, Márquez, Antonia, Vicente, David, García-Sáenz, José Angel, Martín, Miguel
Published in Breast cancer research and treatment (01.07.2010)
Published in Breast cancer research and treatment (01.07.2010)
Get full text
Journal Article
Phase II study with conventional radiotherapy (RT) + cetuximab in patients with advanced larynx cancer who responded to induction chemotherapy (IC): An organ preservation TTCC study
Mesia, Ricard, Garcia Saenz, Jose Angel, Lozano, Alicia, Pastor, Miguel, Grau, Juan José, Martinez Trufero, Javier, Lambea- Sorrosal, Julio Jose, Martinez Galan, Joaquina, Mel, Jose Ramón, Gonzalez, Belen, Vazquez, Silvia, Manos Pujol, Manel, Taberna, Miren, Cirauqui, Beatriz, del Barco, Elvira, Casado, Esther, Rubió, Jordi, Rodriguez Jaraiz, Angeles, Cruz, Juan J.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02)
Vázquez, Sergio, Huidobro, Gerardo, Amenedo, Margarita, Fírvida, José Luis, León, Luis, Lázaro, Martín, Grande, Carlos, Mel, José Ramón, Ramos, Manuel, Salgado, Mercedes, Casal, Joaquín
Published in Anti-cancer drugs (01.11.2007)
Published in Anti-cancer drugs (01.11.2007)
Get more information
Journal Article
Value of circulating epithelial tumor cells and circulating endothelial cells (CTCs/CECs) in patients with HER2-negative recurrent or metastatic breast cancer treated with bevacizumab (B) in combination with paclitaxel (P) and gemcitabine (G) as first-line therapy (AVALUZ trial)
Codes, Manuel, Manso, Luis, Ciruelos, Eva M., De la Haba- Rodriguez, Juan, Galan, Antonio, Baena, Jose Manuel, Jaen, Ana, Gil, Miquel, Murias, Adolfo, Blancas, Isabel, Gonzalez, Encarnacion, Perez, Diego, Bayo, Juan L., Mel, Jose Ramón, Garcia-Martinez, Elena, Cubedo, Ricardo, Salvador, Javier
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: OS analysis
Salvador, Javier, Ciruelos, Eva M., Codes, Manuel, Jaen, Ana, Gil, Miquel, Galan, Antonio, Murias, Adolfo, Jara-Sanchez, Carlos, De la Haba- Rodriguez, Juan, Baena, Jose Manuel, Villanueva Silva, Maria Jose, Bayo, Juan L., Blancas, Isabel, Gonzalez, Encarnacion, Perez, Diego, Mel, Jose Ramón, Manso, Luis
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
Martín, Miguel, Rodríguez-Lescure, Álvaro, Ruiz, Amparo, Alba, Emilio, Calvo, Lourdes, Ruiz-Borrego, Manuel, Munárriz, Blanca, Rodríguez, César A., Crespo, Carmen, de Alava, Enrique, López García-Asenjo, José Antonio, Guitián, María Dolores, Almenar, Sergio, González-Palacios, Jesús Fernando, Vera, Francisco, Palacios, José, Ramos, Manuel, Gracia Marco, Jose Manuel, Lluch, Ana, Alvarez, Isabel, Seguí, Miguel Angel, Mayordomo, José Ignacio, Antón, Antonio, Baena, José Manuel, Plazaola, Arrate, Modolell, Alfonso, Pelegrí, Amadeu, Mel, Jose Ramón, Aranda, Enrique, Adrover, Encarna, Álvarez, José Valero, García Puche, José Luis, Sánchez-Rovira, Pedro, Gonzalez, Sonia, López-Vega, José Manuel
Published in JNCI : Journal of the National Cancer Institute (04.06.2008)
Published in JNCI : Journal of the National Cancer Institute (04.06.2008)
Get full text
Journal Article
Phase II trial of vinorelbine and estramustine in the treatment of metastatic hormone-resistant prostate cancer
Borrega, Pablo, Velasco, Amalia, Bolaños, Matilde, del Mar Páerez, Maráia, Mel, Josáe Ramáon, Reina, Juan Josáe, Rodráiguez-Jaraiz, Maráia Angeles, Chaves, Manuel, Gonzáalez-Baráon, Manuel
Published in Urologic oncology (2004)
Published in Urologic oncology (2004)
Get full text
Journal Article
P2-317: Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC). A phase II study of the Lung Cancer Galician Group
Vázquez-Estévez, Sergio, Fírvida, José Luis, Huidobro, Gerardo, León, Luis, Lázaro, Martín, Pérez, Eva, Álvarez, Elen, Casal, Joaquín, Salgado, Mercedes, Mel, José Ramón
Published in Journal of thoracic oncology (01.08.2007)
Published in Journal of thoracic oncology (01.08.2007)
Get full text
Journal Article
Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00)
Vázquez, Sergio, Grande, Carlos, Amenedo, Margarita, Fírvida, José Luis, Lázaro, Martín, Alonso, Guillermo, Curiel, Teresa, Huidobro, Gerardo, Mel, José Ramón, Ramos, Manuel
Published in Anti-cancer drugs (01.06.2004)
Published in Anti-cancer drugs (01.06.2004)
Get more information
Journal Article